Long-Term Outcome of Neonates and Infants whose Mothers Tested Positive for SARS-CoV-2 during Pregnancy – a Pilot of the Post-CRONOS Project
Zeitschrift für Geburtshilfe und Neonatologie · 2024-02 · 228 (01) · 97-101
DOI: 10.1055/a-2213-9061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Geburtshilfe und Neonatologie, online erschienen am 08.02.2024. Verfasst von Nadine Mand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology and Pediatric Intensive Care, University of Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
Long-term effects on infants of mothers with SARS-CoV-2 infection during pregnancy are increasingly discussed in the literature. Besides potential neurodevelopment impairments after intrauterine SARS-CoV-2 exposure, there might be differences in the postnatal pediatric care of those children, like the timing of preventive medical examinations (PME) or vaccinations. In this first national long-term follow-up study of women included in the CRONOS registry, we describe maternal impressions of their child´s development and the prevalence of regulatory disorders, and we analyze the timing of PMEs and vaccinations.
Methods
773 women who were enrolled between April 3, 2020, and August 24, 2021, in the CRONOS registry were eligible to be contacted by the study coordinators and asked to fill out a web-based questionnaire.
Results
110/773 (14%) women completed the questionnaire. Their children were between the ages of 12 and 31 months (median 20 months). All mothers were satisfied with their child´s development, milestones were achieved in a timely fashion. The reported prevalence for excessive crying, sleeping, and feeding disorders was 11%, 18–32%, and 7%, respectively. PMEs were mostly not delayed, but only 54% of infants received their first vaccination within their first 60 days of life.
Discussion
In summary, our exploratory findings suggest that developmental milestones in infancy are reached in time after maternal SARS-CoV-2 infection during pregnancy. However, there are effects on the implementation of PMEs and vaccinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neonatology and Pediatric Intensive Care, University of Marburg, Marburg, Germany.
- Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
- Department of Obstetrics, University Hospital Würzburg, Maternal Health and Midwifery Science, Würzburg, Germany.
- Department of Gynecology and Obstetrics, University of Marburg, Marburg, Germany.
- Department of Obstetrics and Gynecology, Munich Hospital Harlaching, Munich, Germany.
- Department of Pediatrics, Maastricht University, Maastricht, Netherlands.
ORCID-Profile: Nadine Mand, Corinna Nora Keil
Zitieren
APA
Mand, N., König, F., Pecks, U., Keil, C. N., Backes, C., Hütten, M., Maier, R. F., & Ruediger, M. (2024). Long-Term Outcome of Neonates and Infants whose Mothers Tested Positive for SARS-CoV-2 during Pregnancy – a Pilot of the Post-CRONOS Project. Zeitschrift für Geburtshilfe und Neonatologie, 228(01), 97-101. https://doi.org/10.1055/a-2213-9061
Vancouver
Mand N, König F, Pecks U, Keil CN, Backes C, Hütten M, et al. Long-Term Outcome of Neonates and Infants whose Mothers Tested Positive for SARS-CoV-2 during Pregnancy – a Pilot of the Post-CRONOS Project. Zeitschrift für Geburtshilfe und Neonatologie. 2024;228(01):97-101. doi:10.1055/a-2213-9061
BibTeX
@article{Mand2024,
author = {Mand, Nadine and König, Franziska and Pecks, Ulrich and Keil, Corinna Nora and Backes, Clara and Hütten, Matthias and Maier, Rolf Felix and Ruediger, Mario},
title = {Long-Term Outcome of Neonates and Infants whose Mothers Tested Positive for SARS-CoV-2 during Pregnancy – a Pilot of the Post-CRONOS Project},
journal = {Zeitschrift für Geburtshilfe und Neonatologie},
year = {2024},
volume = {228},
number = {01},
pages = {97--101},
doi = {10.1055/a-2213-9061}
}
EUVIMED